Aldevron has named Brian Walters, President of its antibody business unit and Tom Foti President of its protein business unit.
Aldevron is scheduled to present, exhibit and conduct one-on-one meetings at the Biotechnology Innovation Organization’s (BIO) International Convention, June 3 – 6, 2019, in Philadelphia. Aldevron’s James Brown, VP Corporate Development, is speaking on standardized helper plasmids for viral vector production.
Aldevron has expanded its leadership team by appointing Michelle Berg President of its GMP nucleic acids business unit. She will report to Michael Chambers, Aldevron’s founder and CEO.
Andy Rodgers has joined Aldevron as its Director of Operational Excellence. In his position, Rodgers will be responsible for developing, implementing and managing strategies and objectives to ensure the achievement of the company’s goals to improve performance, quality, delivery and cost.
Lance Monilaws of Aldevron has been promoted as its Director of Industrial Project Management. In his position, Monilaws will direct large capital projects with emphasis in facility expansion, renovation and campus planning. He will also manage various operational initiatives and strategies, including but not limited to construction and industrial technology.
Ally Hauser of Aldevron has been promoted to Director of Client Relations for Protein Services. In her position, Hauser will lead new projects and initiatives to expand research grade and cGMP protein services to the benefit of our clients.
Tom Foti, Vice President and General Manager of Aldevron's Madison site, discussed the addition of a 1,000 liter fermentor and significant expansion of the site's manufacturing space at the American Society of Gene & Cell Therapy conference in Washington, DC.
